Clinical Trial Update: First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study assessing safety, PK/PD, and food effect of single and repeat doses of GSK3439171A in healthy subjects, completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscular Dystrophy

Drugs mentioned

• GSK3439171A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Muscular Dystrophies | Phase 1 | Status: COMPLETED | Results posted: 2020-07-10